John is a Managing Director on the life sciences team at Westwicke Partners. He joined in 2007 and works with public and private companies in biotechnology, specialty pharmaceuticals, nutraceuticals and diagnostics.
John has over 20 years’ Wall Street and industry experience. Previously, he was a Life Sciences Equity Research analyst at Legg Mason Wood Walker, Inc., now part of Stifel Nicolaus, with a focus on early stage drug discovery companies and pharmaceutical service and product suppliers.
John has also worked as Director of Finance and Strategic Planning at Lentigen Corporation, a venture-stage biotechnology company, with responsibility for corporate positioning, strategy and capital raising. He began his career in operational roles at Primedica Corporation, now a subsidiary of Charles River Labs, and MedImmune, Inc., now a subsidiary of AstraZeneca International.
John received an MBA from the R.H. Smith School of Business and a BS degree in Microbiology from the University of Maryland at College Park.